ZA882562B - Sulfonyldecahydro-8h-isoquino-(2,1-g)(1,6)-naphthyridines,optical isomers thereof and related compounds - Google Patents

Sulfonyldecahydro-8h-isoquino-(2,1-g)(1,6)-naphthyridines,optical isomers thereof and related compounds

Info

Publication number
ZA882562B
ZA882562B ZA882562A ZA882562A ZA882562B ZA 882562 B ZA882562 B ZA 882562B ZA 882562 A ZA882562 A ZA 882562A ZA 882562 A ZA882562 A ZA 882562A ZA 882562 B ZA882562 B ZA 882562B
Authority
ZA
South Africa
Prior art keywords
lower alkyl
sulfonyldecahydro
isoquino
naphthyridines
optical isomers
Prior art date
Application number
ZA882562A
Other languages
English (en)
Inventor
Robin D Clark
D Clark Robin
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of ZA882562B publication Critical patent/ZA882562B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA882562A 1987-04-13 1988-04-12 Sulfonyldecahydro-8h-isoquino-(2,1-g)(1,6)-naphthyridines,optical isomers thereof and related compounds ZA882562B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/037,320 US4791108A (en) 1987-04-13 1987-04-13 Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers

Publications (1)

Publication Number Publication Date
ZA882562B true ZA882562B (en) 1989-12-27

Family

ID=21893706

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882562A ZA882562B (en) 1987-04-13 1988-04-12 Sulfonyldecahydro-8h-isoquino-(2,1-g)(1,6)-naphthyridines,optical isomers thereof and related compounds

Country Status (20)

Country Link
US (1) US4791108A (da)
EP (1) EP0288196B1 (da)
JP (1) JP2527784B2 (da)
KR (1) KR960007864B1 (da)
AT (1) ATE92066T1 (da)
AU (1) AU613610B2 (da)
CA (1) CA1331459C (da)
DE (1) DE3882571T2 (da)
DK (2) DK171106B1 (da)
ES (1) ES2058264T3 (da)
FI (1) FI88162C (da)
HU (2) HU199469B (da)
IE (1) IE60624B1 (da)
IL (1) IL86039A (da)
MX (1) MX11083A (da)
NO (1) NO170805C (da)
NZ (1) NZ224221A (da)
PH (1) PH25961A (da)
PT (1) PT87219B (da)
ZA (1) ZA882562B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956365A (en) * 1987-04-13 1990-09-11 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds
US4886798A (en) * 1987-04-13 1989-12-12 Syntex (U.S.A.) Inc. Optical isomers of sulfonyldecahydro-8H-isoquino-(2,1-G)(1,6) naphthyridines and related compounds useful as α2 -blockers
US4960891A (en) * 1987-04-13 1990-10-02 Syntex (U.S.A.) Inc. Process for the preparation of decahydro-8H-isoquino[2,1-g][1,6]naphthyridine derivatives
GB9012469D0 (en) * 1990-06-05 1990-07-25 Glaxo Group Ltd Medicaments
US5231181A (en) * 1991-03-21 1993-07-27 Syntex (U.S.A.) Inc. Process for the preparation of (8as,12as,13as)-decahydroisoquino ((2,1-g) (1,6)-naphthyridin-8-one derivatives
FI923267L (fi) * 1991-07-17 1993-01-18 Syntex Inc Dekahydro-8h-isokino(2,1-g) (1,6)naftyridin- och dekahydrobenso(a)pyrrolo(2,3-e)-kinolizinderivat
US5229387A (en) * 1991-09-20 1993-07-20 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives
JP2005519110A (ja) * 2002-03-04 2005-06-30 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 新規なケイ皮酸塩、その調製方法及び医薬品としての使用
CN103387583B (zh) * 2012-05-09 2018-04-13 中国科学院上海药物研究所 二芳基并[a,g]喹嗪类化合物、其制备方法、药物组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953598A (en) * 1972-09-08 1976-04-27 The Upjohn Company Compounds, compositions and methods of use
GB1513824A (en) * 1975-05-22 1978-06-14 Wyeth John & Brother Ltd 1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizine derivative
US4353911A (en) * 1979-07-20 1982-10-12 Andre Buzas Indolo(2,3-a)quinolizidines, useful in increasing femoral and vertebral blood flow
CH645653A5 (de) * 1980-08-01 1984-10-15 Ciba Geigy Ag Quaternaere, copolymere, hochmolekulare ammoniumsalze auf acrylbasis, deren herstellung und verwendung als aktive komponente in kosmetischen mitteln.
US4454139A (en) * 1980-08-28 1984-06-12 John Wyeth & Brother, Limited α2 -Adrenoceptor antagonistic benzoquinolizines
GB8302499D0 (en) * 1983-01-29 1983-03-02 Wyeth John & Brother Ltd Benzoquinolizines
US4690928A (en) * 1984-02-02 1987-09-01 Merck & Co., Inc. Substituted hexahydro arylquinolizines as α2 blockers
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility

Also Published As

Publication number Publication date
MX11083A (es) 1993-04-01
FI88162B (fi) 1992-12-31
DK199388A (da) 1988-10-14
EP0288196B1 (en) 1993-07-28
NO881574L (no) 1988-10-14
DK84693A (da) 1993-07-15
PT87219A (pt) 1988-05-01
NO881574D0 (no) 1988-04-12
AU613610B2 (en) 1991-08-08
HU210349A9 (en) 1995-03-28
DK199388D0 (da) 1988-04-12
NZ224221A (en) 1990-07-26
NO170805C (no) 1992-12-09
DE3882571T2 (de) 1994-01-20
KR880012601A (ko) 1988-11-28
FI881687A0 (fi) 1988-04-12
DK84693D0 (da) 1993-07-15
IL86039A0 (en) 1988-09-30
ATE92066T1 (de) 1993-08-15
FI881687A7 (fi) 1988-10-14
DE3882571D1 (de) 1993-09-02
AU1450288A (en) 1988-10-13
US4791108A (en) 1988-12-13
PH25961A (en) 1992-01-13
DK171106B1 (da) 1996-06-10
ES2058264T3 (es) 1994-11-01
KR960007864B1 (ko) 1996-06-13
EP0288196A1 (en) 1988-10-26
NO170805B (no) 1992-08-31
JP2527784B2 (ja) 1996-08-28
PT87219B (pt) 1992-12-31
HU199469B (en) 1990-02-28
IE881097L (en) 1988-10-13
HUT47107A (en) 1989-01-30
JPS63277679A (ja) 1988-11-15
IE60624B1 (en) 1994-07-27
CA1331459C (en) 1994-08-16
FI88162C (fi) 1993-04-13
IL86039A (en) 1993-05-13

Similar Documents

Publication Publication Date Title
IL69912A (en) Substituted 1-hydroxyethyltriazolyl derivatives,their preparation and their use as plant protection agents
AU1450288A (en) Sulfonyldecahydro-8h-isoquino-(2,1-g) (1,6)-naphthyridines, optical isomers thereof and related compounds
ZA862278B (en) Novel(4.2.0)bicyclooctane derivatives with valuable therapeutic properties
PH19797A (en) Thiazol-4-yl pyrimidone derivatives useful as antiulcer agents
HUT53365A (en) Process for producing 1,8-benzonaphthyridine derivatives
EP0574271A3 (da)
CA2007760A1 (fr) Nouveaux derives de benzonaphtyridine-1,8, leur preparation et les compositions qui les contiennent
GR3020488T3 (en) Benzo(b)thiophene-2-carboxamides for the treatment of disorders of the central nervous system
FI883507A0 (fi) Naftotiazepinderivat och deras framstaellning.
HU905000D0 (en) Process for producing compounds suitable for treatment of gastric ulcer
EP0364254A3 (en) Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine derivatives and related compounds
EP0289935A3 (en) Stabilizing mixture of organic compounds of sulphur and organic compounds of nitrogen, use of the mixture in stabilizing oxyalkylene glycol alkyl ethers
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
DE3362036D1 (en) Ketene-o,o-acetates and process for their preparation
IN161663B (da)
GB2071093B (en) Benzothiopyrano(2,3-c)pyridines